NIH-funded research R21 grant

How obesity affects cancer treatment in endometrial cancer patients

Official title: Impact of Obesity on Immuno-Oncology Agents in Endometrial Cancer

Funded at Univ of North Carolina Chapel Hill · NIH-10672881 · Data updated 2026-11-12

This study is looking at how being overweight affects the success of certain cancer treatments for women with endometrial cancer, and it aims to find better ways to help those patients by combining two specific medications.

More Obesity research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startAugust 1, 2022
Project endJuly 31, 2025
Funding year2024
Award (this year)$172,653
NIH project number5R21CA267584-02
Project IDNIH-10672881 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are obese patients diagnosed with endometrial cancer.

Less likely to help

Patients who are not obese or do not have endometrial cancer may not benefit from this research.

What this research studies

This research investigates the impact of obesity on the effectiveness of immuno-oncology treatments for endometrial cancer. It focuses on how obesity influences the immune response and the expression of specific proteins that are targeted by cancer therapies. The study will explore the combination of atezolizumab, an anti-PD-L1 antibody, with ONC201, a small molecule that may enhance treatment efficacy. By understanding these interactions, the research aims to improve treatment outcomes for obese patients with endometrial cancer.

Why it matters

Potential benefit: If successful, this research could lead to more effective cancer treatments for obese patients with endometrial cancer.

How similar studies have gone: Other research has shown promising results with immuno-oncology treatments in similar contexts, but this specific approach is relatively novel.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Bae-Jump, Victoria Lin — Univ of North Carolina Chapel Hill
  • Study coordinator: Bae-Jump, Victoria Lin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.